Donald Kruppa
Geschäftsführer bei Azaya Therapeutics, Inc.
Profil
Donald Kruppa is currently the Director at The Health Cell and the Vice President-Operations at Azaya Therapeutics, Inc. He previously worked as the Senior Director-Portfolio & Program management at ICON Clinical Research, Inc., as well as in various roles at Abbott Laboratories, ILEX Oncology, Inc., Genzyme Corp., and OncoNano Medicine, Inc. Mr. Kruppa completed his undergraduate degree at Texas A&M University and holds an MBA from The University of Texas at Austin.
Aktive Positionen von Donald Kruppa
| Unternehmen | Position | Beginn |
|---|---|---|
Azaya Therapeutics, Inc.
 Azaya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Azaya Therapeutics, Inc. develops pharmaceutical products and systems. The firm offers contract development and manufacturing services, such as chemical testing, liposomal manufacturing services to speed drug development and regulatory progress for pharmaceutical, medical device developers and meet customers’ academic or commercial needs. The company was founded by John C. Kerr in 2003 and is headquartered in San Antonio, TX. | Geschäftsführer | 01.01.2012 |
| The Health Cell | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Donald Kruppa
| Unternehmen | Position | Ende |
|---|---|---|
OncoNano Medicine, Inc.
 OncoNano Medicine, Inc. BiotechnologyHealth Technology OncoNano Medicine, Inc. operates as a biotechnology company. It develops pH-activated compounds that digitalize and exploit the variability of pH in disease. The company was founded by Ravi Srinivasan, Jinming Gao, and Baran Sumer in 2014 and is headquartered in Southlake, TX. | Geschäftsführer | 01.03.2024 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
ILEX Oncology, Inc.
 ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | Corporate Officer/Principal | - |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
ICON Clinical Research, Inc.
 ICON Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services ICON Clinical Research, Inc. provides research and consulting services. It services include clinical research, biometrics, interactive technologies, laboratory, clinical pharmacology and consulting services. The company was founded by John Climax and Ronan Lambe in 1990 and is headquartered in North Wales, PA | Corporate Officer/Principal | - |
Ausbildung von Donald Kruppa
| Texas A&M University | Undergraduate Degree |
| The University of Texas at Austin | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| Private Unternehmen | 6 |
|---|---|
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Azaya Therapeutics, Inc.
Azaya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Azaya Therapeutics, Inc. develops pharmaceutical products and systems. The firm offers contract development and manufacturing services, such as chemical testing, liposomal manufacturing services to speed drug development and regulatory progress for pharmaceutical, medical device developers and meet customers’ academic or commercial needs. The company was founded by John C. Kerr in 2003 and is headquartered in San Antonio, TX. | Health Technology |
ICON Clinical Research, Inc.
ICON Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services ICON Clinical Research, Inc. provides research and consulting services. It services include clinical research, biometrics, interactive technologies, laboratory, clinical pharmacology and consulting services. The company was founded by John Climax and Ronan Lambe in 1990 and is headquartered in North Wales, PA | Commercial Services |
| The Health Cell | |
OncoNano Medicine, Inc.
OncoNano Medicine, Inc. BiotechnologyHealth Technology OncoNano Medicine, Inc. operates as a biotechnology company. It develops pH-activated compounds that digitalize and exploit the variability of pH in disease. The company was founded by Ravi Srinivasan, Jinming Gao, and Baran Sumer in 2014 and is headquartered in Southlake, TX. | Health Technology |
